Paul S Gaynon

5PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersPaediatrics not elsewhere classifiedAdolescent healthCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 06, 2024
Clinical Relapse Versus Treatment Failure: The Case for Surveillance for Re-Appearance of Minimal Measurable Disease in Pediatric Patients with Higher Risk B-ALL.

Paul S Gaynon, Linwei Li

|May 13, 2024
Development of second genetically distinct T-lymphoblastic leukemia in a pediatric patient.

Haley Hultquist, Alyssa Rodriguez, Juanita E Ferreira

|Aug 22, 2022
Nelarabine, etoposide, and cyclophosphamide in relapsed pediatric T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma (study T2008-002 NECTAR).

James A Whitlock, Jemily Malvar, Luciano Dalla-Pozza

|Feb 21, 2022
Survival of pediatric Hodgkin lymphoma patients treated with doxorubicin, bleomycin, vincristine, etoposide, prednisone, and cyclophosphamide (ABVE-PC) versus doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) at a single institution.

Sebastian de Armas, Carolina Huertas-Ayala, Randall Y Chan

|Jul 24, 2021
A new standard of care for childhood T-cell acute lymphoblastic leukemia?

Paul S Gaynon, Chintan Parekh

Pageof 1

Frequent Collaborators

1 joint publications

Alexandra E Kovach

1 joint publications

Chintan Parekh

1 joint publications

Randall Y Chan

1 joint publications

Winston W Huh